FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

1197405007: Product containing precisely efavirenz 400 milligram and lamivudine 300 milligram and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 milligram/1 each conventional release oral tablet (clinical drug)


Status: current, Defined. Date: 28-Feb 2022. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
4696218013 Product containing precisely efavirenz 400 milligram and lamivudine 300 milligram and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Case insensitive SNOMED CT core
4696219017 Efavirenz 400 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet en Synonym Active Case insensitive SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Efavirenz 400 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet Is a Efavirenz and lamivudine and tenofovir only product in oral dose form true Inferred relationship Some
Efavirenz 400 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet Has manufactured dose form Conventional release oral tablet true Inferred relationship Some
Efavirenz 400 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet Has unit of presentation Tablet true Inferred relationship Some
Efavirenz 400 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet Plays role Antiretroviral therapeutic role true Inferred relationship Some
Efavirenz 400 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet Has precise active ingredient Lamivudine true Inferred relationship Some 1
Efavirenz 400 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet Has BoSS Lamivudine true Inferred relationship Some 1
Efavirenz 400 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet Has presentation strength numerator unit mg true Inferred relationship Some 1
Efavirenz 400 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet Has presentation strength denominator unit Tablet true Inferred relationship Some 1
Efavirenz 400 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet Has precise active ingredient Efavirenz true Inferred relationship Some 2
Efavirenz 400 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet Has BoSS Efavirenz true Inferred relationship Some 2
Efavirenz 400 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet Has presentation strength numerator unit mg true Inferred relationship Some 2
Efavirenz 400 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet Has presentation strength denominator unit Tablet true Inferred relationship Some 2
Efavirenz 400 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet Has precise active ingredient Tenofovir disoproxil fumarate true Inferred relationship Some 3
Efavirenz 400 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet Has BoSS Tenofovir disoproxil true Inferred relationship Some 3
Efavirenz 400 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet Has presentation strength numerator unit mg true Inferred relationship Some 3
Efavirenz 400 mg and lamivudine 300 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet Has presentation strength denominator unit Tablet true Inferred relationship Some 3

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start